Decibel Therapeutics Inc is a biotechnology business based in the US. Decibel Therapeutics shares (DBTX) are listed on the NASDAQ and all prices are listed in US Dollars. Decibel Therapeutics employs 62 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Decibel Therapeutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – DBTX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Our top pick for
Beginners

Our top pick for
Building a portfolio

Our top pick for
Advanced traders

Decibel Therapeutics stock price (NASDAQ: DBTX)
Use our graph to track the performance of DBTX stocks over time.Decibel Therapeutics shares at a glance
Latest market close | $2.24 |
---|---|
52-week range | $1.83 - $9.75 |
50-day moving average | $2.27 |
200-day moving average | $4.70 |
Wall St. target price | $16.00 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-2.20 |
Buy Decibel Therapeutics shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Decibel Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Decibel Therapeutics price performance over time
Historical closes compared with the close of $2.24 from 2022-06-27
1 week (2022-06-21) | -3.45% |
---|---|
1 month (2022-05-27) | -4.27% |
3 months (2022-03-29) | -23.81% |
6 months (2021-12-29) | -52.54% |
1 year (2021-06-29) | -75.00% |
---|---|
2 years (2020-06-25) | N/A |
3 years (2019-06-25) | N/A |
5 years (2017-06-25) | N/A |
Decibel Therapeutics financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -17.51% |
Return on equity TTM | -35.65% |
Profit margin | 0% |
Book value | $5.13 |
Market capitalisation | $62.2 million |
TTM: trailing 12 months
Decibel Therapeutics share dividends
We're not expecting Decibel Therapeutics to pay a dividend over the next 12 months.
Decibel Therapeutics overview
Decibel Therapeutics, Inc. , a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders. Its product candidates and programs focuses on three areas, such as Gene Therapies for Congenital, Monogenic Hearing Loss designed to restore functional cells within the cochlea to address hearing disorders caused by single gene mutations; Gene Therapies for Hair Cell Regeneration designed to replace lost hair cells within the inner ear to address acquired hearing loss and balance disorders; and Otoprotection Therapeutic in clinical development to prevent hearing loss in cancer patients undergoing chemotherapy with cisplatin. The company's lead gene therapy product candidate is DB-OTO to provide hearing to individuals born with profound hearing loss due to mutation of the otoferlin gene. It is also developing DB-ATO and AAV. 201, a gene therapy program designed to restore balance in patients with bilateral vestibulopathy by regenerating lost hair cells within the vestibule; DB-020 for the prevention of cisplatin-induced hearing loss, which is in Phase 1b clinical trial; AAV. 103 to restore hearing in individuals with a gap junction beta-2 (GJB2) deficiency; AAV.
Decibel Therapeutics in the news
Decibel Therapeutics Reports Positive Data from Interim Analysis of Ongoing Phase 1b Clinical Trial of DB-020 in Patients Receiving Cisplatin Chemotherapy
Decibel Therapeutics Reports Positive Data from Interim Analysis of Ongoing Phase 1b Clinical Trial of DB-020 in Patients Receiving Cisplatin Chemotherapy
Decibel Therapeutics to Present at the Jefferies Global Healthcare Conference
Frequently asked questions
What percentage of Decibel Therapeutics is owned by insiders or institutions?Currently 20.2% of Decibel Therapeutics shares are held by insiders and 64.535% by institutions. How many people work for Decibel Therapeutics?
Latest data suggests 62 work at Decibel Therapeutics. When does the fiscal year end for Decibel Therapeutics?
Decibel Therapeutics's fiscal year ends in December. Where is Decibel Therapeutics based?
Decibel Therapeutics's address is: 1325 Boylston Street, Boston, MA, United States, 02215 What is Decibel Therapeutics's ISIN number?
Decibel Therapeutics's international securities identification number is: US24343R1068
More guides on Finder
-
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
-
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
-
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
-
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
-
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
-
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
-
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
-
How to buy Warrantee (WRNT) stock when it goes public
Everything we know about the Warrantee IPO, plus information on how to buy in.
-
How to buy Treasure Global (TGL) stock when it goes public
Everything we know about the Treasure Global IPO, plus information on how to buy in.
-
How to buy BIOLIFE4D (SAVU) stock when it goes public
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
Ask an Expert